Literature DB >> 16891175

Role of protein tyrosine phosphatases in cancer.

Tasneem Motiwala1, Samson T Jacob.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16891175      PMCID： PMC3077959          DOI： 10.1016/S0079-6603(06)81008-1

Source DB:  PubMed          Journal:  Prog Nucleic Acid Res Mol Biol        ISSN： 0079-6603


× No keyword cloud information.
  161 in total

Review 1.  Gene repair and transposon-mediated gene therapy.

Authors:  Paul D Richardson; Lance B Augustin; Betsy T Kren; Clifford J Steer
Journal:  Stem Cells       Date:  2002       Impact factor: 6.277

2.  Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells.

Authors:  Z Ivics; P B Hackett; R H Plasterk; Z Izsvák
Journal:  Cell       Date:  1997-11-14       Impact factor: 41.582

3.  Overexpression of a nuclear protein tyrosine phosphatase increases cell proliferation.

Authors:  V Radha; S Nambirajan; G Swarup
Journal:  FEBS Lett       Date:  1997-06-02       Impact factor: 4.124

4.  Common physical properties of DNA affecting target site selection of sleeping beauty and other Tc1/mariner transposable elements.

Authors:  Thomas J Vigdal; Christopher D Kaufman; Zsuzsanna Izsvák; Daniel F Voytas; Zoltán Ivics
Journal:  J Mol Biol       Date:  2002-10-25       Impact factor: 5.469

Review 5.  PTEN and myotubularin: novel phosphoinositide phosphatases.

Authors:  T Maehama; G S Taylor; J E Dixon
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

6.  Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design.

Authors:  Y A Puius; Y Zhao; M Sullivan; D S Lawrence; S C Almo; Z Y Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

7.  Protein tyrosine phosphatase epsilon increases the risk of mammary hyperplasia and mammary tumors in transgenic mice.

Authors:  A Elson
Journal:  Oncogene       Date:  1999-12-09       Impact factor: 9.867

8.  Cytogenetical assignment and physical mapping of the human R-PTP-kappa gene (PTPRK) to the putative tumor suppressor gene region 6q22.2-q22.3.

Authors:  Y Zhang; R Siebert; P Matthiesen; Y Yang; H Ha; B Schlegelberger
Journal:  Genomics       Date:  1998-07-15       Impact factor: 5.736

9.  SOCS1 and SHP1 hypermethylation in multiple myeloma: implications for epigenetic activation of the Jak/STAT pathway.

Authors:  Chor-Sang Chim; Tsz-Kin Fung; Wai-Chung Cheung; Raymond Liang; Yok-Lam Kwong
Journal:  Blood       Date:  2004-02-19       Impact factor: 22.113

10.  Synthesis and biological activity of a novel class of pyridazine analogues as non-competitive reversible inhibitors of protein tyrosine phosphatase 1B (PTP1B).

Authors:  Charlotta Liljebris; Jessica Martinsson; Lars Tedenborg; Meredith Williams; Emma Barker; James E S Duffy; Alf Nygren; Stephen James
Journal:  Bioorg Med Chem       Date:  2002-10       Impact factor: 3.641
View more
  21 in total

Review 1.  Tumour suppressor function of protein tyrosine phosphatase receptor-T.

Authors:  Anthony Scott; Zhenghe Wang
Journal:  Biosci Rep       Date:  2011-10       Impact factor: 3.840

2.  Label-Free Assay of Protein Tyrosine Phosphatase Activity in Single Cells.

Authors:  Elamar Hakim Moully; Eric J Berns; Milan Mrksich
Journal:  Anal Chem       Date:  2019-09-26       Impact factor: 6.986

3.  PTP1B expression contributes to gastric cancer progression.

Authors:  Jinguo Wang; Bingya Liu; Xuehua Chen; Liping Su; Pei Wu; Jian Wu; Zhenggang Zhu
Journal:  Med Oncol       Date:  2011-03-27       Impact factor: 3.064

Review 4.  PTPN13/PTPL1: an important regulator of tumor aggressiveness.

Authors:  Gilles Freiss; Dany Chalbos
Journal:  Anticancer Agents Med Chem       Date:  2011-01       Impact factor: 2.505

5.  Loss of Tyrosine Phosphatase Delta Promotes Gastric Cancer Progression via Signal Transducer and Activator of Transcription 3 Pathways.

Authors:  Lei Wu; Lanying Gao; Decai Kong; Hongfeng Xue
Journal:  Dig Dis Sci       Date:  2019-04-30       Impact factor: 3.199

6.  PTPROt inactivates the oncogenic fusion protein BCR/ABL and suppresses transformation of K562 cells.

Authors:  Tasneem Motiwala; Sarmila Majumder; Kalpana Ghoshal; Huban Kutay; Jharna Datta; Satavisha Roy; David M Lucas; Samson T Jacob
Journal:  J Biol Chem       Date:  2008-11-07       Impact factor: 5.157

7.  Methylation of the PTPRO gene in human hepatocellular carcinoma and identification of VCP as its substrate.

Authors:  Shu-hao Hsu; Tasneem Motiwala; Satavisha Roy; Rainer Claus; Mufaddal Mustafa; Christoph Plass; Michael A Freitas; Kalpana Ghoshal; Samson T Jacob
Journal:  J Cell Biochem       Date:  2013-08       Impact factor: 4.429

8.  Increased processing of SINE B2 ncRNAs unveils a novel type of transcriptome deregulation in amyloid beta neuropathology.

Authors:  Yubo Cheng; Luke Saville; Babita Gollen; Christopher Isaac; Abel Belay; Jogender Mehla; Kush Patel; Nehal Thakor; Majid H Mohajerani; Athanasios Zovoilis
Journal:  Elife       Date:  2020-11-16       Impact factor: 8.140

9.  Estrogen-mediated suppression of the gene encoding protein tyrosine phosphatase PTPRO in human breast cancer: mechanism and role in tamoxifen sensitivity.

Authors:  Bhuvaneswari Ramaswamy; Sarmila Majumder; Satavisha Roy; Kalpana Ghoshal; Huban Kutay; Jharna Datta; Mamoun Younes; Charles L Shapiro; Tasneem Motiwala; Samson T Jacob
Journal:  Mol Endocrinol       Date:  2008-12-18

Review 10.  Cellular prostatic acid phosphatase, a PTEN-functional homologue in prostate epithelia, functions as a prostate-specific tumor suppressor.

Authors:  Sakthivel Muniyan; Matthew A Ingersoll; Surinder K Batra; Ming-Fong Lin
Journal:  Biochim Biophys Acta       Date:  2014-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.